Zhang, Yunlin
Patel, Ruchi P.
Kim, Ki Hyun
Cho, Hyungwoo
Jo, Jae-Cheol
Jeong, Seong Hyun
Oh, Sung Yong
Choi, Yoon Seok
Kim, Sung Hyun
Lee, Ji Hyun
Angelos, Mathew
Guruprasad, Puneeth
Cohen, Ivan
Ugwuanyi, Ositadimma
Lee, Yong Gu
Pajarillo, Raymone
Cho, Jong Hyun
Carturan, Alberto
Paruzzo, Luca
Ghilardi, Guido
Wang, Michael
Kim, Soohwan
Kim, Sung-Min
Lee, Hyun-Jong
Park, Ji-Ho
Cui, Leiguang
Lee, Tae Bum
Hwang, In-Sik
Lee, Young-Ha
Lee, Yong-Jun
Porazzi, Patrizia
Liu, Dongfang
Lee, Yoon
Kim, Jong-Hoon
Lee, Jong-Seo
Yoon, Dok Hyun
Chung, Junho
Ruella, Marco
Funding for this research was provided by:
AbClon Inc. (Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella), Sponsored Research Agreement (PI: Dr. Marco Ruella))
AbClon Inc Clinical Trial Grant
Article History
Received: 25 August 2023
Accepted: 23 October 2023
First Online: 9 December 2023
Declarations
:
: MR holds patents related to CD19 CAR T cells (non-AT101) which are licensed to Novartis, Tmunity (Kite-Gilead), and viTToria Biotherapeutics. MR has served as a consultant for NanoString, BMS, GSK, GLG, Sana, Bayer, Guidepoint, Scailyte, and AbClon. MR receives research funding from AbClon, Beckman Coulter, CurioX, Oxoford Nano Imaging, and viTToria Biotherapeutics. MR is the scientific founder of viTToria biotherapeutics. RPP and GG received honoraria for consultation with viTToria Biotherapeutics. DHY has served as a consultant for Roche, Janssen, Amgen, BMS, Novartis, AbClon, GI cell, GC cell, and Pharos Bio. DHY receives honoraria from Roche, Janssen, Amgen, BMS, Kirin, Boryung, and Takeda. DHY receives research funding from Samyang, Kirin, Roche, Janssen and Boryung.